“I’m optimistic and believe Shingrix will also be effective at reducing shingles and its sequelae, especially with how effective the vaccine has shown to be in other settings,” said Harris. Harris ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit vaccine -- Ten shingles cases would have been expected absent ...

Scientists have developed a vaccine for shingles, the unpleasant and often extremely painful condition which, it is estimated, affects around one third of the population at some point in their lives.

30, missing market expectations of 238 million pounds, while sales of shingles vaccine, Shingrix, fell 7% to 739 million pounds, also below estimates in a company compiled consensus. Walmsley told ...

Jiangsu Recbio Technology Co., Ltd. Class H (HK:2179) has released an update. Jiangsu Recbio Technology has launched a phase III clinical trial in China for its novel shingles vaccine, REC610 ...

Study published in Nature Medicine found that the recombinant shingles vaccine is linked to a reduced risk of dementia. This protective effect was particularly notable in females, suggesting a ...

Belfast, Maine: Let us not make momentous decisions based on anger. Doing so has started many wars that hurt all involved, forever. Government has always been corrupted by money and the power that ...

Nova Scotia's Progressive Conservatives promised on Tuesday to introduce a universal shingles vaccine program for people 65 and older if re-elected Nov. 26, the latest in a series of targeted ...

Finally, it’s too late for your mother, but older people who have not had the newer two-dose shingles vaccine (Shingrix) should get it, even if they had the old one-dose vaccine (Zostavax ...

Amezosvatein and Shingrix are adjuvanted recombinant protein subunit vaccines targeting glycoprotein E (gE), the most abundant glycoprotein expressed on the surface of the varicella zoster virus ...

Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit vaccine -- Ten shingles cases would have been expected ...

(Reuters) -GSK (GSK) on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory syncytial virus (RSV) and shingles vaccines in the third ...